A detailed history of Lazard Asset Management LLC transactions in Illumina, Inc. stock. As of the latest transaction made, Lazard Asset Management LLC holds 23,148 shares of ILMN stock, worth $3.13 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
23,148
Previous 24,927 7.14%
Holding current value
$3.13 Million
Previous $2.6 Million 16.03%
% of portfolio
0.0%
Previous 0.0%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$105.28 - $135.9 $187,293 - $241,766
-1,779 Reduced 7.14%
23,148 $3.02 Million
Q2 2024

Aug 14, 2024

SELL
$101.05 - $133.57 $307,899 - $406,987
-3,047 Reduced 10.89%
24,927 $2.6 Million
Q1 2024

May 14, 2024

SELL
$127.73 - $147.2 $272,831 - $314,419
-2,136 Reduced 7.09%
27,974 $3.84 Million
Q4 2023

Feb 14, 2024

SELL
$92.79 - $142.53 $98,914 - $151,936
-1,066 Reduced 3.42%
30,110 $4.19 Million
Q3 2023

Nov 14, 2023

SELL
$128.91 - $192.44 $124,784 - $186,281
-968 Reduced 3.01%
31,176 $4.28 Million
Q2 2023

Aug 14, 2023

BUY
$183.43 - $232.67 $39,620 - $50,256
216 Added 0.68%
32,144 $6.03 Million
Q1 2023

May 15, 2023

BUY
$193.75 - $232.55 $31,968 - $38,370
165 Added 0.52%
31,928 $7.42 Million
Q4 2022

Feb 14, 2023

SELL
$187.24 - $242.74 $3.94 Million - $5.1 Million
-21,021 Reduced 39.82%
31,763 $6.42 Million
Q3 2022

Nov 14, 2022

BUY
$177.23 - $227.44 $307,139 - $394,153
1,733 Added 3.39%
52,784 $10.1 Million
Q2 2022

Aug 09, 2022

BUY
$181.58 - $368.0 $2.74 Million - $5.55 Million
15,084 Added 41.94%
51,051 $9.41 Million
Q1 2022

May 13, 2022

BUY
$303.87 - $423.8 $2.8 Million - $3.9 Million
9,207 Added 34.41%
35,967 $12.6 Million
Q4 2021

Feb 09, 2022

BUY
$347.28 - $421.83 $4.22 Million - $5.12 Million
12,147 Added 83.12%
26,760 $10.2 Million
Q3 2021

Nov 15, 2021

BUY
$405.61 - $524.84 $214,973 - $278,165
530 Added 3.76%
14,613 $5.93 Million
Q2 2021

Aug 12, 2021

BUY
$372.84 - $481.5 $4.02 Million - $5.19 Million
10,775 Added 325.73%
14,083 $6.66 Million
Q1 2021

May 14, 2021

BUY
$361.28 - $504.76 $756,159 - $1.06 Million
2,093 Added 172.26%
3,308 $1.27 Million
Q4 2020

Feb 11, 2021

BUY
$292.7 - $370.96 $71,126 - $90,143
243 Added 25.0%
1,215 $448,000
Q3 2020

Nov 13, 2020

SELL
$268.51 - $400.74 $1.82 Million - $2.71 Million
-6,770 Reduced 87.45%
972 $299,000
Q2 2020

Aug 13, 2020

BUY
$256.46 - $373.01 $1.66 Million - $2.42 Million
6,490 Added 518.37%
7,742 $2.87 Million
Q4 2019

Feb 13, 2020

BUY
$288.29 - $335.49 $153,946 - $179,151
534 Added 74.37%
1,252 $414,000
Q3 2019

Nov 14, 2019

SELL
$266.84 - $378.23 $5.77 Million - $8.18 Million
-21,620 Reduced 96.79%
718 $217,000
Q2 2019

Aug 14, 2019

SELL
$300.59 - $368.15 $32,163 - $39,392
-107 Reduced 0.48%
22,338 $8.22 Million
Q1 2019

May 13, 2019

BUY
$272.57 - $321.18 $1.02 Million - $1.2 Million
3,734 Added 19.96%
22,445 $6.97 Million
Q4 2018

Aug 28, 2019

BUY
$272.46 - $366.54 $3,541 - $4,765
13 Added 0.07%
18,711 $5.61 Million
Q4 2018

Feb 13, 2019

BUY
$272.46 - $366.54 $1.4 Million - $1.88 Million
5,131 Added 37.82%
18,698 $5.61 Million
Q3 2018

Nov 13, 2018

BUY
$279.04 - $367.06 $2.04 Million - $2.68 Million
7,301 Added 116.52%
13,567 $4.98 Million
Q2 2018

Aug 13, 2018

BUY
$228.17 - $292.07 $24,870 - $31,835
109 Added 1.77%
6,266 $1.75 Million
Q1 2018

May 14, 2018

BUY
$209.54 - $253.91 $1.29 Million - $1.56 Million
6,134 Added 26669.57%
6,157 $1.46 Million
Q4 2017

Feb 13, 2018

BUY
$202.23 - $230.03 $4,651 - $5,290
23 New
23 $5,000
Q3 2017

Nov 13, 2017

SELL
$172.3 - $213.93 $1.72 Million - $2.14 Million
-10,000 Closed
0 $0
Q2 2017

Aug 19, 2019

BUY
N/A
8,600 Added 614.29%
10,000 $1.74 Million
Q4 2015

Jul 24, 2019

BUY
N/A
1,400
1,400 $268,000

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $21.2B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Lazard Asset Management LLC Portfolio

Follow Lazard Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.